Drug intelligence / Profile preview

Tongjingning Syrup

Development stage: Unknown
Lead developer: Wuhan Juneng Jinshi Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Tongjingning Syrup is an approved Traditional Chinese Medicine (TCM) formulation manufactured by Wuhan Juneng Jinshi Pharmaceutical (also known as Juneng Golden Key Pharmaceutical). It is a pharmaceutical product registered in China (国药准字号) and is primarily indicated for the treatment of dysmenorrhea (painful menstruation) and the regulation of menstrual cycles. The formulation is based on TCM principles of promoting blood circulation to remove blood stasis and regulating qi to alleviate pain. It is typically administered orally as a syrup or oral liquid and is composed of a combination of herbal ingredients traditionally used in gynecological health.

Brand names: Tongjingning Syrup
Other names: Tongjingning Tangjiang痛经宁糖浆

Beyond the preview

Go deeper on Tongjingning Syrup.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tongjingning Syrup.

Explore the full profile